Multimodal therapy of disseminated ovarian dysgerminoma (case report)
Abstract
Germ-cell tumors are rare, but aggressive tumors in children. The introduction of modern treatment protocols has significantly improved survival in this group of patients. This paper presents the analysis of clinical case of disseminated ovarian dysgerminoma successfully treated using multimodal therapeutic approach. The epidemiology of ovarian dysgerminoma among pediatric patients and the pathogenesis of the disease are discussed based on the analysis of the literature data. We also discuss the basic principles of diagnosis and choice of tactics of treatment.
About the Author
M. A. Alyabieva
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia; 1 Samory Mashela St., Moscow, 117198, Russia
Russian Federation
Russian Federation
References
1. American Cancer Society. Cancer Facts and Figures, 2014. Atlanta, GA: American Cancer Society. http://www.cancer.org/.
2. Gobel U., Schneider D.T., Calaminus G. et al. Germ-cell tumors in childhood and adolescence. Ann Oncol 2000;11(3):263–71.
3. Mangili G., Sigismondi C., Lorusso D., Pignata S. Surveillance policy for stage IA malignant ovarian germ cell tumors in children and young adults. J Clin Oncol 2014;32(25):2814–5.
4. Hanif J. Intra-abdominal tumors in children. J Coll Physicians Surg Pak 2004;14(8):478–80.
5. Weinberg L.E., Lurain J.R., Singh D.K., Schink J.C. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol Oncol 2011;121(2):285–9.
6. Michener C.M., Huh W.K, Wu A.Y. et al. Ovarian Dysgerminomas. Medscape, 2015. http://emedicine.medscape.com/article/253701.
7. Bidus M.A., Elkas J.C., Rose G.S. Clinical Gynecologic Oncology, 8th ed: Saunders, an imprint of Elsevier Inc, 2012. Pp. 329–356.
8. Beryl R.B., Steven R.G., Yvette S.G. Gynecologic Ultrasound: A Problem-Based Approach: Saunders, an imprint of Elsevier Inc, 2014. Pp. 56–57.
9. Hyseni N., Llullaku S., Jashari H. et al. Advanced ovarian dysgerminoma infiltrating both ovaries and uterus in a 7-year-old girl. Case Rep Oncol Med 2014;2014:910852.
10. Florette K., Teri A. Ovarian Dysgerminomas Pathology Overview of Ovarian Dysgerminomas. Medscape, 2013.http://emedicine.medscape.com/article/1951026.
11. Eleftherios P.D., Hervert A.F., Hans L. et al. Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications. Washington, DC: AACC Press, 2002. P. 52.
12. Young G., Toretsky J., Campbell A., Eskenazi A. Recognition of common childhood malignancies. Am Fam Physician 2000;61(7):2144–54.
13. Leman E., Gonzalgo M. Prognostic features and markers for testicular cancer management. Indian J Urol 2010;26(1):76–81.
14. Steyerberg E.W., Habbema J.D. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. Eur J Cancer 2006;42(7):820–6.
Review
For citations:
Alyabieva M.A. Multimodal therapy of disseminated ovarian dysgerminoma (case report). Russian Journal of Pediatric Hematology and Oncology. 2015;2(3):71-75. (In Russ.)
Views:
568
Email this article 